These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 38578578)
1. Comparative Safety and Efficacy of Low/Moderate-Intensity Statin plus Ezetimibe Combination Therapy vs. High-Intensity Statin Monotherapy in Patients with Atherosclerotic Cardiovascular Disease: An Updated Meta-Analysis. Hameed I; Shah SA; Aijaz A; Mushahid H; Farhan SH; Dada M; Khan AB; Amjad R; Alvi F; Murtaza M; Zuberi Z; Hamza M Am J Cardiovasc Drugs; 2024 May; 24(3):419-431. PubMed ID: 38578578 [TBL] [Abstract][Full Text] [Related]
2. Safety and Effectiveness of High-Intensity Statins Versus Low/Moderate-Intensity Statins Plus Ezetimibe in Patients With Atherosclerotic Cardiovascular Disease for Reaching LDL-C Goals: A Systematic Review and Meta-Analysis. Soleimani H; Mousavi A; Shojaei S; Tavakoli K; Salabat D; Farahani Rad F; Askari MK; Nelson J; Ruzieh M; Hosseini K Clin Cardiol; 2024 Aug; 47(8):e24334. PubMed ID: 39135464 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of Statin/Ezetimibe for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Asian Populations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Bhagavathula AS; Aldhaleei WA; Al Matrooshi NO; Rahmani J Clin Drug Investig; 2020 Sep; 40(9):809-826. PubMed ID: 32671595 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of combination therapy with statin and another lipid-modifying agent compared with intensified statin monotherapy: a systematic review. Gudzune KA; Monroe AK; Sharma R; Ranasinghe PD; Chelladurai Y; Robinson KA Ann Intern Med; 2014 Apr; 160(7):468-76. PubMed ID: 24514899 [TBL] [Abstract][Full Text] [Related]
5. Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy. Ballantyne CM; Laufs U; Ray KK; Leiter LA; Bays HE; Goldberg AC; Stroes ES; MacDougall D; Zhao X; Catapano AL Eur J Prev Cardiol; 2020 Apr; 27(6):593-603. PubMed ID: 31357887 [TBL] [Abstract][Full Text] [Related]
6. The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Jamialahmadi T; Baratzadeh F; Reiner Ž; Simental-Mendía LE; Xu S; Susekov AV; Santos RD; Sahebkar A Mediators Inflamm; 2021; 2021():9661752. PubMed ID: 34526854 [TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy. Mikhailidis DP; Sibbring GC; Ballantyne CM; Davies GM; Catapano AL Curr Med Res Opin; 2007 Aug; 23(8):2009-26. PubMed ID: 17659159 [TBL] [Abstract][Full Text] [Related]
8. Comparative safety and efficacy of low- or moderate-intensity statin plus ezetimibe combination therapy and high-intensity statin monotherapy: A meta-analysis of randomized controlled studies. Ah YM; Jeong M; Choi HD PLoS One; 2022; 17(3):e0264437. PubMed ID: 35245303 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of combination therapy with ezetimibe and statins versus a double dose of statin monotherapy in participants with hypercholesterolemia: a meta-analysis of literature. Yu M; Liang C; Kong Q; Wang Y; Li M Lipids Health Dis; 2020 Jan; 19(1):1. PubMed ID: 31900179 [TBL] [Abstract][Full Text] [Related]
10. Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial. Lee SJ; Cha JJ; Choi WG; Lee WS; Jeong JO; Choi S; Cho YH; Park W; Yoon CH; Lee YJ; Hong SJ; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y; Hong SJ; Kim JS; JAMA Cardiol; 2023 Sep; 8(9):853-858. PubMed ID: 37531130 [TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial. Kim BK; Hong SJ; Lee YJ; Hong SJ; Yun KH; Hong BK; Heo JH; Rha SW; Cho YH; Lee SJ; Ahn CM; Kim JS; Ko YG; Choi D; Jang Y; Hong MK; Lancet; 2022 Jul; 400(10349):380-390. PubMed ID: 35863366 [TBL] [Abstract][Full Text] [Related]
12. Moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with metabolic syndrome and atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING trial. Lee YJ; Lee SH; You SC; Lee YH; Lee SJ; Hong SJ; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y; Kim JS Diabetes Obes Metab; 2024 Mar; 26(3):829-839. PubMed ID: 37994242 [TBL] [Abstract][Full Text] [Related]
13. Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation. Ara R; Tumur I; Pandor A; Duenas A; Williams R; Wilkinson A; Paisley S; Chilcott J Health Technol Assess; 2008 May; 12(21):iii, xi-xiii, 1-212. PubMed ID: 18485273 [TBL] [Abstract][Full Text] [Related]
14. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study. Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245 [TBL] [Abstract][Full Text] [Related]
15. Moderate-intensity statin plus ezetimibe vs high-intensity statin according to baseline LDL-C in the treatment of atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING randomized trial. Lee B; Hong SJ; Rha SW; Heo JH; Hur SH; Choi HH; Kim KJ; Kim JH; Kim HK; Kim U; Choi YJ; Lee YJ; Lee SJ; Ahn CM; Ko YG; Kim BK; Choi D; Hong MK; Jang Y; Kim JS Atherosclerosis; 2023 Dec; 386():117373. PubMed ID: 37995599 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the Efficacy of Ezetimibe Combination Therapy and High-Intensity Statin Monotherapy in Type 2 Diabetes. Park SY; Jun JE; Jeong IK; Ahn KJ; Chung HY; Hwang YC J Clin Endocrinol Metab; 2024 Jun; 109(7):1883-1890. PubMed ID: 38175670 [TBL] [Abstract][Full Text] [Related]
17. The impact of the time of drug administration on the effectiveness of combined treatment of hypercholesterolemia with Rosuvastatin and Ezetimibe (RosEze): study protocol for a randomized controlled trial. Obońska K; Kasprzak M; Sikora J; Obońska E; Racki K; Goździkiewicz N; Krintus M; Kubica J Trials; 2017 Jul; 18(1):316. PubMed ID: 28697767 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Efficacy and Safety of Statin-Ezetimibe Combination Therapy with Statin Monotherapy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Studies. Shin KH; Choi HD Am J Cardiovasc Drugs; 2022 Jul; 22(4):395-406. PubMed ID: 34927215 [TBL] [Abstract][Full Text] [Related]
19. Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 subjects from 27 clinical trials. Morrone D; Weintraub WS; Toth PP; Hanson ME; Lowe RS; Lin J; Shah AK; Tershakovec AM Atherosclerosis; 2012 Aug; 223(2):251-61. PubMed ID: 22410123 [TBL] [Abstract][Full Text] [Related]
20. Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacy. Lorenzi M; Ambegaonkar B; Baxter CA; Jansen J; Zoratti MJ; Davies G Clin Res Cardiol; 2019 May; 108(5):487-509. PubMed ID: 30302558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]